CAPRICOR THERAPEUTICS, INC. Proceeds from Warrant Exercises
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Proceeds from Warrant Exercises of $50.56 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2022-03-11
- CAPRICOR THERAPEUTICS, INC. proceeds from warrant exercises for the quarter ending 2020-12-31 was $93.66K, a 20712.22% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. proceeds from warrant exercises for the quarter ending 2020-09-30 was $193.79K.
- CAPRICOR THERAPEUTICS, INC. proceeds from warrant exercises for the quarter ending 2020-06-30 was $5.34M.
- CAPRICOR THERAPEUTICS, INC. proceeds from warrant exercises for the quarter ending 2020-03-31 was $89.29K.
- CAPRICOR THERAPEUTICS, INC. proceeds from warrant exercises for fiscal 2021 was $50.56K, a 99.12% decline from fiscal 2020.
- CAPRICOR THERAPEUTICS, INC. proceeds from warrant exercises for fiscal 2020 was $5.72M, a 1271215.78% increase from fiscal 2019.
- CAPRICOR THERAPEUTICS, INC. proceeds from warrant exercises for fiscal 2019 was $450.00.
- CAPRICOR THERAPEUTICS, INC. proceeds from warrant exercises for fiscal 2018 was $0.00.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month | Proceeds from Warrant Exercises 12 month as first filed |
|---|---|---|---|---|---|
| 2021-12-31 | $50.56K 10-K · filed 2022-03-11 | ||||
| 2020-12-31 | $93.66K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $287.44K derived: sum of 2 quarters · filed 2022-03-11 | $5.63M derived: sum of 3 quarters · filed 2022-03-11 | $5.72M 10-K · filed 2022-03-11 | $5.69M 10-K · filed 2021-03-15 |
| 2020-09-30 | $193.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $5.54M derived: sum of 2 quarters · filed 2021-11-12 | $5.63M 10-Q · filed 2021-11-12 | $5.63M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $5.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $5.43M 10-Q · filed 2021-08-13 | $5.43M derived: sum of 3 quarters · filed 2021-08-13 | $5.43M derived: sum of 4 quarters · filed 2021-08-13 | |
| 2020-03-31 | $89.29K 10-Q · filed 2021-05-14 | $89.74K derived: sum of 2 quarters · filed 2021-05-14 | $89.74K derived: sum of 3 quarters · filed 2021-05-14 | $89.74K derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $450.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $450.00 derived: sum of 2 quarters · filed 2021-03-15 | $450.00 derived: sum of 3 quarters · filed 2021-03-15 | $450.00 10-K · filed 2021-03-15 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $0.00 derived: sum of 2 quarters · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $0.00 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | ||||
| 2018-12-31 | $0.00 10-K · filed 2020-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |